glp 1 stomach acid Indigestion from GLP-1 Injections The OCULUS trial settles the

Xia J, Li Q, Liu Y, Ren Q, Gao J, Tian Y, et al

Having less fat in certain areas of the body often causes the skin to become looser, which can lead to an older-looking appearance

Obesity and insulin resistance sustain elevated circulating concentrations of pro-inflammatory cytokines including Tumour Necrosis Factor-alpha (TNF-), Interleukin-1 (IL-1), and Interleukin-6 (IL-6) molecules that promote DNA damage, tumour angiogenesis, and immune evasion

Even intravenous administration of GLP-1 at a physiological postprandial dose of 0.3 pmol/kg/min significantly slowed the rate of gastric emptying in healthy subjects, bringing them into a state of gastroparesis (Little et al., 2006)

Their continuous investment in research and development, particularly in oral formulations and novel indications, further strengthens their position

Abstract Rationale Obesity remains a major global health challenge, severely affecting metabolic and cardiovascular health